144 related articles for article (PubMed ID: 17896355)
1. Proton MR spectroscopic imaging of the medulla and cervical spinal cord.
Edden RA; Bonekamp D; Smith MA; Dubey P; Barker PB
J Magn Reson Imaging; 2007 Oct; 26(4):1101-5. PubMed ID: 17896355
[TBL] [Abstract][Full Text] [Related]
2. 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil.
Osorio JA; Ozturk-Isik E; Xu D; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
J Magn Reson Imaging; 2007 Jul; 26(1):23-30. PubMed ID: 17659562
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.
Lagemaat MW; Zechmann CM; Fütterer JJ; Weiland E; Lu J; Villeirs GM; Holshouser BA; van Hecke P; Lemort M; Schlemmer HP; Barentsz JO; Roell SO; Heerschap A; Scheenen TW
J Magn Reson Imaging; 2012 Jan; 35(1):166-73. PubMed ID: 21960013
[TBL] [Abstract][Full Text] [Related]
4. Quantitative multivoxel proton spectroscopy of the brain in developmental delay.
Verbruggen KT; Maurits NM; Meiners LC; Brouwer OF; van Spronsen FJ; Sijens PE
J Magn Reson Imaging; 2009 Oct; 30(4):716-21. PubMed ID: 19787717
[TBL] [Abstract][Full Text] [Related]
5. The earliest MR imaging and proton MR spectroscopy abnormalities in adult-onset Krabbe disease.
Wang C; Melberg A; Weis J; Månsson JE; Raininko R
Acta Neurol Scand; 2007 Oct; 116(4):268-72. PubMed ID: 17824908
[TBL] [Abstract][Full Text] [Related]
6. Metabolic assessment of the human pons by in vivo proton magnetic resonance spectroscopy.
Guan JT; Xu XH; Geng YQ; Yu XJ; Wu RH
Brain Res; 2008 Aug; 1227():221-5. PubMed ID: 18602897
[TBL] [Abstract][Full Text] [Related]
7. Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias.
Guerrini L; Belli G; Mazzoni L; Foresti S; Ginestroni A; Della Nave R; Diciotti S; Mascalchi M
J Magn Reson Imaging; 2009 Jul; 30(1):11-7. PubMed ID: 19557841
[TBL] [Abstract][Full Text] [Related]
8. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence.
Chen AP; Cunningham CH; Kurhanewicz J; Xu D; Hurd RE; Pauly JM; Carvajal L; Karpodinis K; Vigneron DB
Magn Reson Imaging; 2006 Sep; 24(7):825-32. PubMed ID: 16916699
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of optimal echo time for 1H-spectroscopic imaging of brain tumors at 3 Tesla.
Hattingen E; Pilatus U; Franz K; Zanella FE; Lanfermann H
J Magn Reson Imaging; 2007 Aug; 26(2):427-31. PubMed ID: 17654728
[TBL] [Abstract][Full Text] [Related]
10. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
Zacharia TT; Law M; Naidich TP; Leeds NE
J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
Laprie A; Catalaa I; Cassol E; McKnight TR; Berchery D; Marre D; Bachaud JM; Berry I; Moyal EC
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):773-81. PubMed ID: 18262090
[TBL] [Abstract][Full Text] [Related]
13. Anatomical and metabolic assessment of prostate using a 3-Tesla MR scanner with a custom-made external transceive coil: healthy volunteer study.
Kaji Y; Kuroda K; Maeda T; Kitamura Y; Fujiwara T; Matsuoka Y; Tamura M; Takei N; Matsuda T; Sugimura K
J Magn Reson Imaging; 2007 Mar; 25(3):517-26. PubMed ID: 17279524
[TBL] [Abstract][Full Text] [Related]
14. Proton MR spectroscopic imaging without water suppression.
van Der Veen JW; Weinberger DR; Tedeschi G; Frank JA; Duyn JH
Radiology; 2000 Oct; 217(1):296-300. PubMed ID: 11012460
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study.
Sajja BR; Narayana PA; Wolinsky JS; Ahn CW;
Mult Scler; 2008 Jan; 14(1):73-80. PubMed ID: 17881390
[TBL] [Abstract][Full Text] [Related]
17. Brainstem signs with progressing atrophy of medulla oblongata and upper cervical spinal cord.
Romano S; Salvetti M; Ceccherini I; De Simone T; Savoiardo M
Lancet Neurol; 2007 Jun; 6(6):562-70. PubMed ID: 17509491
[No Abstract] [Full Text] [Related]
18. Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T.
Li Y; Osorio JA; Ozturk-Isik E; Chen AP; Xu D; Crane JC; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
Magn Reson Imaging; 2006 Dec; 24(10):1295-302. PubMed ID: 17145400
[TBL] [Abstract][Full Text] [Related]
19. Central neurocytoma: proton MR spectroscopy and diffusion weighted MR imaging findings.
Kocaoglu M; Ors F; Bulakbasi N; Onguru O; Ulutin C; Secer HI
Magn Reson Imaging; 2009 Apr; 27(3):434-40. PubMed ID: 18789624
[TBL] [Abstract][Full Text] [Related]
20. Fast three-dimensional 1H MR spectroscopic imaging at 7 Tesla using "spectroscopic missing pulse--SSFP".
Schuster C; Dreher W; Stadler J; Bernarding J; Leibfritz D
Magn Reson Med; 2008 Nov; 60(5):1243-9. PubMed ID: 18836998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
